Delivery Order SPE2DB25D3012-SPE2DB25FWWNE

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,434.76, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,364.30 firm fixed-price delivery order is for the supply of 0.5 mL syringes of the PEDIARIX vaccine, with a completion date of February 13, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,957.60, is for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,363.82, is for the supply of PEDIARIX 0.5 ML SYRINGE 0.0.5ML, a pediatric vaccine. The contract has an ultimate completion date of October 2, 2023 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a $9,621.66 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 0.5 mL PEDIARIX syringes, a pediatric vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,113.10, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,526.44 to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine, with a period of performance through March 25, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,238.36, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The contract has an ultimate completion date of January 17, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a $15,222.32 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 0.5 mL syringes of the PEDIARIX vaccine. The order has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other government healthcare programs. The contract is not associated with any set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,524.30, is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract is a firm fixed price, delivery order contract with a completion date of February 14, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWNE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,332.30, is for the procurement of 0.5 mL syringes of the PEDIARIX vaccine. The contract has an ultimate completion date of April 1, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/30/25, 10:47 AM